LN Future Invest AB, formerly Ellen AB, is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Companyâ€™s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others.

Employees

Sector

Personal Products

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm Other stock markets 04:00:00 24/02/26 am AEDT			5-day change	1st Jan Change
0.9250 ^SEK	+6.94%		-.--%	+10.78%

26/02	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
16/02	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI

Market Cap	10.25M 1.08M 936K 872K 802K 1.51M 103M 1.53M 4.02M 51.39M 4.06M 3.97M 170M	P/E 2024	-8.92x	P/E 2025	1.23x
Enterprise Value	-2.44M -257K -223K -207K -191K -360K -24.43M -364K -957K -12.23M -965K -944K -40.49M	EV / Sales 2024	0.37x	EV / Sales 2025	-0.24x
Free-Float	39.6%	Yield 2024 *	-	Yield 2025	75.4%

26/02	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
16/02	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI
27/01	LN Future Invest to Be Delisted from First North, Last Trading Day Set for February 23	FW
27/01	Nasdaq Stockholm to delist LN Future Invest shares on Feb 23	RE
04/09/25	Ln Future Invest begins work on reverse acquisition opportunities	RE
29/08/25	Ln Future Invest H1 net sales at SEK 11.3 mln	RE
29/08/25	LN Future Invest AB Reports Earnings Results for the Half Year Ended June 30, 2025	CI
20/08/25	Ellen Completes Business Transfer to Addeira Pharmaceuticals	FW
10/07/25	Ellen enters into conditional agreement to sell business	RE
09/07/25	Addeira Pharmaceuticals Ab agreed to acquire Business of Ellen AB from Ellen AB (OM:ELN) for SEK 13.3 million.	CI
27/05/25	Ellen Q1 EBITDA Falls To SEK 102,000	RE
28/02/25	Ellen H2 EBIT Loss SEK 1 Mln	RE
28/02/25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI

1 day	+6.94%
6 months	+4.52%
Current year	+10.78%

Ellen AB Stock

Stocks

LNFI

SE0014730347

Personal Products

Valuation: Ellen AB

Chart: Ellen AB

Latest news : Ellen AB

Press Releases: Ellen AB

Quotes and Performance

Course Extremes

Managers and Directors: Ellen AB

Sanitary Products

Financials

Company Profile

Income Statement and Estimates

Current year	0.75	0.92
1 year	0.58	1.35
3 years	0.49	2
5 years	0.49	7.58
10 years	0.49	79

Manager	Title	Age	Since
Sofia Fredrikson CEO	Chief Executive Officer	43	-
Sven Olof Mattsson IRC	Investor Relations Contact	65	01/05/2021
Lena De Wall ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Jan Fredrik Mikael Lövgren BRD	Director/Board Member	65	09/07/2004
Sven Olof Mattsson CHM	Chairman	65	01/01/2025
Sofia Fredrikson BRD	Director/Board Member	43	18/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELLEN AB	+6.94%	-.--%	-22.27%	-14.35%	1.1M
KIMBERLY-CLARK CORPORATION	+0.72%	-0.74%	-16.27%	-12.05%	37.11B
UNICHARM CORPORATION	+3.24%	-2.47%	-2.66%	-47.26%	10.9B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	-0.34%	-8.35%	+1.63%	-22.36%	3.52B
SOFTCARE LIMITED	-1.47%	+1.27%	-	-	2.68B
GILLETTE INDIA LIMITED	+0.29%	-2.61%	-28.26%	+35.04%	2.62B
OIL-DRI CORPORATION OF AMERICA	-0.31%	-0.50%	+73.00%	+207.44%	1.42B
C&S PAPER CO.,LTD	-0.41%	+1.66%	-5.53%	-32.97%	1.39B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	-0.88%	+2.02%	-42.96%	-7.59%	939M
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	-0.54%	+1.90%	-39.05%	-25.25%	768M
Average	+0.72%	-0.17%	-9.15%	+8.96%	6.14B
Weighted average by Cap.	+0.87%	-0.72%	-11.51%	-12.38%

	2024	2025
Net sales	23.48M 2.47M 2.14M 2M 1.84M 3.47M 235M 3.51M 9.22M 118M 9.29M 9.09M 390M	14.15M 1.49M 1.29M 1.2M 1.11M 2.09M 142M 2.11M 5.55M 70.93M 5.6M 5.48M 235M
Net income	-1.24M -131K -113K -106K -97.21K -184K -12.45M -186K -487K -6.23M -492K -481K -20.63M	7.51M 791K 685K 639K 588K 1.11M 75.23M 1.12M 2.95M 37.64M 2.97M 2.91M 125M
Net Debt	-2.43M -256K -221K -206K -190K -359K -24.32M -363K -952K -12.17M -961K -939K -40.3M	-12.69M -1.34M -1.16M -1.08M -993K -1.87M -127M -1.9M -4.98M -63.61M -5.02M -4.91M -211M